Health-conscious individuals
People already investing in nutrition, fitness, preventive assessments or health tracking who want to add molecular-level information to their routine.
Explore proactive healthThe miRoncol vision begins with proactive, asymptomatic health: establish molecular context early, preserve it over time and use validated applications to support earlier, physician-guided decisions.
The broader miRoncol platform includes research directions beyond the current miCheckup cancer test. Product eligibility, availability and intended use should always be confirmed on miCheckup.
These profiles are not diagnoses or automatic eligibility categories. They describe the people most likely to value proactive molecular information and a longer view of their health.
People already investing in nutrition, fitness, preventive assessments or health tracking who want to add molecular-level information to their routine.
Explore proactive healthIndividuals who know disease has affected their family and want to understand the distinction between inherited predisposition and signals of current biological activity.
Explore family-history contextThose who already know they carry an inherited risk factor and want to discuss additional, non-genetic information with their healthcare provider.
Explore genetic-risk contextThose who see preventive health as more than lifespan and want earlier information that may help preserve more healthy, independent years.
Explore healthy agingPeople using nutrition, fitness, health coaching or integrative care who want molecular information connected to their wellness practices without being confused with them.
Explore preventive wellnessPeople exploring whether voluntary preventive testing may fit their personal Health Spending Account, with privacy, eligibility and coverage kept clear.
Explore HSA accessAn early-detection test should never become a reason to delay evaluation of a new symptom or to stop established screening.
This summary is not a complete eligibility or safety disclosure. Confirm the current criteria on miCheckup before ordering.
miRoncol explains the company, platform and research direction. miCheckup explains the current Early Cancer Detection Test.

For microRNA science, AI-assisted interpretation, longitudinal intelligence, four major chronic disease areas and corporate partnerships.
Explore the platform
For eligibility, availability, ordering, blood collection, performance disclosures, results and physician-guided follow-up.
Visit the Early Cancer Detection TestmiRoncol is building the broader intelligence system. miCheckup is the dedicated destination for today’s oncology application.